Price target
49.200.000.00%
The 15 analysts offering 1 year price forecasts for BEAM have a max estimate of — and a min estimate of —.
Analyst rating
Based on 18 analysts giving stock ratings to BEAM in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
BEAM EPS for the last quarter is −1.17 USD despite the estimation of −1.18 USD. In the next quarter EPS is expected to reach −1.25 USD. Track more of Beam Therapeutics Inc. financials and stay on top of what is up with the company.
In the next quarter Beam Therapeutics Inc. revenue is expected to reach 16.24 M USD. Check out Beam Therapeutics Inc. revenue and earnings and make informed decisions.
According to analysts, BEAM price target is 49.20 USD with a max estimate of 80.00 USD and a min estimate of 23.00 USD. Check if this forecast comes true in a year, meanwhile watch Beam Therapeutics Inc. stock price chart and keep track of the current situation with BEAM news and stock market news.
We've gathered opinions of 18 analysts rating BEAM stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.